摘要
目的:通过平喘汤与舒利迭疗效比较,探讨哮喘缓解期中药治疗的意义。方法:选择我院门诊哮喘缓解期患者178例,分为中药组、舒利迭组、对照组,通过临床症状控制率、肺功能指标、诱导痰嗜酸性粒细胞计数百分比及血清IgE指标的治疗前后比较,研究平喘汤对缓解期哮喘患者的疗效。结果:中药组与舒利迭组中,上述四方面指标治疗前后都有显著差异(P<0.01),但两组之间比较无统计学意义。结论:平喘汤有与舒利迭相当的疗效,可作为哮喘患者缓解期有利的治疗选择。
Objective: To investigate the therapy significance of antiasthma decoctions in asthma catabasis,compared with seretide.Methods: The 178 outpatients in asthma catabasis were separated into three groups: traditional medicine group,seretide group and control group.The therapeutic effect of antiasthma decoction was studied through clinical symptoms control rate,lung functional parameter,eosinophil percentage in sputum and IgE variance in serum.Results:Compared prior treatment with post one in traditional medicine group or seretide group,there was significant deviation(P0.01),but there was no statistical significance between the two groups.Conclusions: The antiasthma decoctions is a good selection and its therapeutic effect corresponds with seretide in asthma catabasis.
出处
《激光杂志》
CAS
CSCD
北大核心
2011年第3期82-83,共2页
Laser Journal
基金
重庆市卫生局厅级资助项目(2008-2-224)
关键词
平喘汤
舒利迭
哮喘缓解期
疗效
antiasthma decoctions
seretide
asthma catabasis
therapeutic effect